Nachrichten zur Seres Therapeutics Inc Aktie

The human microbiome market is projected to expand at a CAGR of 20.42%, growing from $941.215 million in 2025 to…

Wall Streets main indexes were on track for a lower open on Tuesday as the Israel-Iran conflict entered its fifth…

The mean of analysts price targets for Seres Therapeutics (MCRB) points to a 713.1% upside in the stock. While this…

…

Seres Therapeutics chief legal officer sells $2,939 in stock…

Seres Therapeutics executive sells shares worth $2,058…

…

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today…

CAMBRIDGE, Mass, June 07, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a…

Seres Therapeutics executive sells shares worth $882…

Seres Therapeutics executive sells shares worth $660…

Seres Therapeutics CEO sells $2,288 in stock…

…

Seres Therapeutics stock target cut to $5, maintains Outperform rating…

…

…

Seres Therapeutics appoints new CFO as Arkowitz retires…